Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
GE Healthcare |
---|---|
Information provided by: | GE Healthcare |
ClinicalTrials.gov Identifier: | NCT00209404 |
Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.
Condition | Intervention | Phase |
---|---|---|
Coronary Artery Disease |
Drug: Iodixanol 320 mg I/Ml |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | DXV407 |
Study First Received: | August 18, 2005 |
Last Updated: | October 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00209404 |
Health Authority: | France: Ministry of Health; Germany: Federal Institute for Drugs and Medical Devices; Spain: Ministry of Health and Consumption |
MDCT Coronary Artery Heart Rate Image Quality Diagnostic Quality |
Arterial Occlusive Diseases Coronary Disease Heart Diseases Myocardial Ischemia |
Vascular Diseases Arteriosclerosis Ischemia Coronary Artery Disease |
Cardiovascular Diseases |